Genenta Science Sets Stockholder Meeting Date
Ticker: GNTA · Form: 6-K · Filed: Apr 2, 2024 · CIK: 1838716
| Field | Detail |
|---|---|
| Company | Genenta Science S.P.A. (GNTA) |
| Form Type | 6-K |
| Filed Date | Apr 2, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-event, shareholder-meeting
Related Tickers: GNTA
TL;DR
Genenta Science (GNTA) is holding its stockholder meeting on April 29, 2024, virtually.
AI Summary
Genenta Science S.p.A. announced on March 29, 2024, the date for its Ordinary and Extraordinary Meeting of Stockholders. The meeting will be held virtually, and related materials will be provided to shareholders.
Why It Matters
This filing informs shareholders about an upcoming key corporate event, the annual meeting, where important decisions are typically made.
Risk Assessment
Risk Level: low — This is a routine corporate filing announcing a shareholder meeting, with no immediate financial or operational impact disclosed.
Key Players & Entities
- Genenta Science S.p.A. (company) — Registrant
- March 29, 2024 (date) — Date of notice for stockholder meeting
- April 29, 2024 (date) — Date of Ordinary and Extraordinary Meeting of Stockholders
FAQ
What is the purpose of the Ordinary and Extraordinary Meeting of Stockholders?
The filing does not specify the exact agenda items for the meeting, only that it is an Ordinary and Extraordinary Meeting.
When will the materials for the virtual annual meeting be available?
The filing states that materials relating to the upcoming virtual annual meeting will be provided, but does not specify the exact date they will be made available.
Is Genenta Science S.p.A. required to file a Form 20-F?
Yes, the filing indicates with a checkmark that the registrant files annual reports under cover of Form 20-F.
What was Genenta Science's former name?
The company's former name was Genenta Science S.r.l., with a date of name change on January 4, 2021.
Where is Genenta Science S.p.A. located?
The company's principal executive offices are located at Via Olgettina No. 58, 20132 Milan, Italy.
Filing Stats: 240 words · 1 min read · ~1 pages · Grade level 9.2 · Accepted 2024-04-02 17:13:01
Filing Documents
- form6-k.htm (6-K) — 19KB
- ex99-1.htm (EX-99.1) — 28KB
- 0001493152-24-012851.txt ( ) — 48KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. GENENTA SCIENCE S.P.A. By: /s/ Richard B. Slansky Name: Richard B. Slansky Title: Chief Financial Officer Dated: April 2, 2024